Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
cancer
clinical trials
life sciences
national blog main
national top stories
startups
biology
boston blog main
boston top stories
crispr therapeutics
deals
gene therapy
medicaid
national
new york blog main
roche
acquisitions
adeno-associated virus
advanced therapies
american society of clinical oncology (asco)
anti-inflammatory drugs
arcturus therapeutics
atmp
avexis
avrobio
bioprocess insider
bms
boston
boulder/denver blog main
boulder/denver top stories
brammer bio
brexanolone
bristol-myers squibb
camp4 therapeutics
cancer immunotherapy
car-t
car-t chimeric antigen receptor
catalent
cell & gene
What
focus
5
×
called
company
gene
key
medicines
new
regenerative
therapeutics
access
adding
addition
advanced
ago
ahead
aiming
alltrna
ambien
american
announced
annual
asco
attendees
attention
balance
based
betting
biopharmaceutical
biotech
build
camp’s
cancer
capacity
car
cash
celgene
cell
cells
celularity
chicago
Language
unset
Current search:
focus
×
biotech
×
@techcrunch.com
2 years ago
Flagship Pioneering’s new venture is betting on tRNA to treat “thousands of diseases”
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
@techcrunch.com
6 years ago
With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas
